Partnership for Prevention
A nonpartisan organization of business, nonprofit and government leaders working to make evidence based disease prevention and health promotion a national priority.
home
|
contact us
|
sitemap
Search:
About Us
Mission
Members of Partnership for Prevention
Become a Member
Board of Directors
Council of Advisors
Committees
Staff
Employment
Driving Directions
Guiding Principles of Corporate Partnership
News Room
Press Releases
Video Archive
Events
Topics
Tobacco Control
Worksite Health
Leading by Example
Investing in Health Workplace Guide
Influenza Immunization
Immunization Policy
Clinical Prevention
National Commission on Prevention Priorities
National Chlamydia Coalition
Health Professionals Roundtable
Community Prevention
Action Guides
Transportation and Health
Obesity, Activity, and Nutrition
Alcohol Abuse and Misuse
Initiatives
Health Reform
Congressional Briefings
Improving Adult Immunization Rates of Today and Preventing the Pandemic Tomorrow
Impact of Tobacco Tax Increase on Demand for Cessation Care
What's so Bad about Living Longer
Averting a Health Care Meltdown
Scoring Prevention-Centered Legislation
Keeping America Healthy through Worksite Health Promotion
Fit at Work-The Importance of Worksite Physical Activity
An Unhealthy America
How to Save 100K Lives
Worksite Health Promotion Improving Health and Controlling Costs
Podcast Series on Increasing
Tobacco Use Prevention and Cessation What We Know Works
Action to Quit - Tobacco Cessation
National Commission on Prevention Priorities
Rankings of Preventive Services for the US Population
Reports and Articles
Preventive Care
Media Resources
Health Professionals Roundtable
Members' Page
Aspirin Use
Leading by Example
Leading by Example Participating CEOs and Organizations
LBE Alumni
National Chlamydia Coalition
Action Guides
The Community Health Promotion Handbook
Diabetes Self Management Education
Places for Physical Activity
School Based Physical Education
Social Support for Physical Activity
Healthcare Provider Reminder Systems
National Coalition for Sexual Health
Publications & Resources
Online Store
Become a Member
Explore prevent.org
Business & Health
Select a Topic
Overview
Clinical Prevention
Community Prevention
Health Reform
Immunization Policy
Obesity, Activity, and Nutrition
Tobacco
Worksite Health
Research
Select a Topic
Overview
Alcohol Abuse
Clinical Prevention
Community Prevention
Immunization Policy
Obesity, Activity, and Nutrition
Tobacco
Worksite Health
Policy & Advocacy
Select a Topic
Overview
Alcohol Abuse
Clinical Prevention
Community Prevention
Health Reform
Immunization Policy
Obesity, Activity, and Nutrition
Tobacco
Worksite Health
Clinical Prevention
Select a Topic
Overview
Alcohol Abuse
Clinical Prevention
Health Reform
Immunization Policy
Obesity, Activity, and Nutrition
Tobacco
Worksite Health
Community Prevention
Select a Topic
Overview
Alcohol Abuse
Community Prevention
Obesity, Activity, and Nutrition
Tobacco
Worksite Health
Prevention Matters Blog
Prevention Matters Podcast
Influenza Immunization
Advisory Committee on Immunization Practices (ACIP) Recommendation
ACIP recommends annual vaccination among people aged 65 years and older and among people aged 50-64 years because this group has an elevated prevalence of certain chronic medical conditions.
FACTS:
The flu is more than a bad cold; it may also result in hospitalization or death.
The single best way to protect against getting influenza is to get a flu shot each fall.
Among working-age adults, both injected and nasal flu vaccinations reduce absenteeism and presenteeism.1,2
This service's
Technical Report (pdf)
includes details on the literature used and approach taken to estimate this service's health impact and cost effectiveness.
Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000 Oct 4;284(13):1655-63.
Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 2003 May 16;21(17-18):2207-17.
About Us
Newsroom
Events
Topics
Initiatives
Publications & Resources
Contact Us
Sitemap
© 2013 Partnership for Prevention. All Rights Reserved.